{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:17:18Z","timestamp":1787008638459,"version":"build-2736575974"},"reference-count":81,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2022,1,28]],"date-time":"2022-01-28T00:00:00Z","timestamp":1643328000000},"content-version":"am","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>Renal replacement therapy (RRT) in cirrhotic patients encompasses a number of issues related to the particular characteristics of this population, especially in the intensive care unit (ICU) setting. The short-term prognosis of cirrhotic patients with acute kidney injury is poor, with a mortality rate higher than 65% in patients with RRT requirement, raising questions about the futility of its initiation. Regarding the management of the RRT itself, there is still no consensus with respect to the modality (continuous versus intermittent) or the anticoagulation required to improve the circuit life, which is shorter than similar at-risk populations, despite the altered haemostasis in traditional coagulation tests frequently found in these patients. Furthermore, volume management is one of the most complex issues in this cohort, where tools used for ambulatory dialysis have not yet been successfully reproducible in the ICU setting.<\/jats:p>\n                  <jats:p>This review attempts to shed light on the management of acute RRT in the critically ill cirrhotic population based on the current evidence and the newly available tools. We will discuss the timing of RRT initiation and cessation, the modality, anticoagulation and fluid management, as well as the outcomes of the RRT in this population, and provide a brief review of the albumin extracorporeal dialysis from the point of view of a nephrologist.<\/jats:p>","DOI":"10.1093\/ckj\/sfac025","type":"journal-article","created":{"date-parts":[[2022,1,25]],"date-time":"2022-01-25T07:23:37Z","timestamp":1643095417000},"source":"Crossref","is-referenced-by-count":10,"title":["Management of acute renal replacement therapy in critically ill cirrhotic patients"],"prefix":"10.1093","author":[{"given":"Jimena","family":"Del Risco-Zevallos","sequence":"first","affiliation":[{"name":"Nephrology and Renal Transplantation Department, Hospital Cl\u00ednic de Barcelona. University of Barcelona, IDIBAPS, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6461-4170","authenticated-orcid":false,"given":"Alicia Molina","family":"And\u00fajar","sequence":"additional","affiliation":[{"name":"Nephrology and Renal Transplantation Department, Hospital Cl\u00ednic de Barcelona. University of Barcelona, IDIBAPS, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gast\u00f3n","family":"Pi\u00f1eiro","sequence":"additional","affiliation":[{"name":"Nephrology and Renal Transplantation Department, Hospital Cl\u00ednic de Barcelona. University of Barcelona, IDIBAPS, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enric","family":"Reverter","sequence":"additional","affiliation":[{"name":"Liver and Digestive ICU, Liver Unit, Hospital Cl\u00ednic de Barcelona, University of Barcelona, IDIBAPS, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N\u00e9stor David","family":"Toapanta","sequence":"additional","affiliation":[{"name":"Liver and Digestive ICU, Liver Unit, Hospital Cl\u00ednic de Barcelona, University of Barcelona, IDIBAPS, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miquel","family":"Sanz","sequence":"additional","affiliation":[{"name":"Liver and Digestive ICU, Liver Unit, Hospital Cl\u00ednic de Barcelona, University of Barcelona, IDIBAPS, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0789-7992","authenticated-orcid":false,"given":"Miquel","family":"Blasco","sequence":"additional","affiliation":[{"name":"Nephrology and Renal Transplantation Department, Hospital Cl\u00ednic de Barcelona. University of Barcelona, IDIBAPS, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Fern\u00e1ndez","sequence":"additional","affiliation":[{"name":"Liver and Digestive ICU, Liver Unit, Hospital Cl\u00ednic de Barcelona, University of Barcelona, IDIBAPS, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6492-024X","authenticated-orcid":false,"given":"Esteban","family":"Poch","sequence":"additional","affiliation":[{"name":"Nephrology and Renal Transplantation Department, Hospital Cl\u00ednic de Barcelona. University of Barcelona, IDIBAPS, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,1,28]]},"reference":[{"key":"2022031703413039400_bib1","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1111\/j.1572-0241.2001.03958.x","article-title":"Risk factors for the development of renal dysfunction in hospitalized patients with cirrhosis","volume":"96","author":"Hampel","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"2022031703413039400_bib2","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1007\/s00134-005-2842-7","article-title":"The attributable mortality of acute renal failure in critically ill patients with liver cirrhosis","volume":"31","author":"Du Cheyron","year":"2005","journal-title":"Intensive Care Med"},{"key":"2022031703413039400_bib3","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1097\/MEG.0b013e328308bb9c","article-title":"Cirrhotics admitted to intensive care unit: the impact of acute renal failure on mortality","volume":"21","author":"Cholongitas","year":"2009","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"2022031703413039400_bib4","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1097\/CCM.0000000000002961","article-title":"Incidence and outcomes for patients with cirrhosis admitted to the United Kingdom critical care units","volume":"46","author":"McPhail","year":"2018","journal-title":"Crit Care Med"},{"key":"2022031703413039400_bib5","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1111\/liv.13389","article-title":"Renal replacement therapy in critically ill liver cirrhotic patients-outcome and clinical implications","volume":"37","author":"Staufer","year":"2017","journal-title":"Liver Int"},{"key":"2022031703413039400_bib6","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.jhep.2018.03.024","article-title":"EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis","volume":"69","author":"European Association for the Study of the Liver","year":"2018","journal-title":"J Hepatol"},{"key":"2022031703413039400_bib7","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1053\/j.gastro.2010.07.043","article-title":"Prognostic importance of the cause of renal failure in patients with cirrhosis","volume":"140","author":"Martin-Llah\u00ed","year":"2011","journal-title":"Gastroenterology"},{"key":"2022031703413039400_bib8","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.jhep.2014.12.029","article-title":"Diagnosis and management of acute kidney injury in patients with cirrhosis: revised consensus recommendations of the International Club of Ascites","volume":"62","author":"Angeli","year":"2015","journal-title":"J Hepatol"},{"key":"2022031703413039400_bib9","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.cgh.2016.09.156","article-title":"Validation of a staging system for acute kidney injury in patients with cirrhosis and association with acute-on-chronic liver failure","volume":"15","author":"Huelin","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2022031703413039400_bib10","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1007\/s00134-012-2523-2","article-title":"Prevalence and outcome of cirrhosis patients admitted to UK intensive care: a comparison against dialysis-dependent chronic renal failure patients","volume":"38","author":"O'Brien","year":"2012","journal-title":"Intensive Care Med"},{"key":"2022031703413039400_bib11","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1097\/MCC.0b013e32835f0c17","article-title":"Cirrhotic patients in the ICU: prognostic markers and outcome","volume":"19","author":"Saliba","year":"2013","journal-title":"Curr Opin Crit Care"},{"key":"2022031703413039400_bib12","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1097\/MEG.0b013e3283544816","article-title":"Improvement in the prognosis of cirrhotic patients admitted to an intensive care unit, a retrospective study","volume":"24","author":"Galbois","year":"2012","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"2022031703413039400_bib13","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.1365-2036.2006.02998.x","article-title":"Review article: scoring systems for assessing prognosis in critically ill adult cirrhotics","volume":"24","author":"Cholongitas","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"2022031703413039400_bib14","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1111\/j.1365-2036.2006.02842.x","article-title":"Risk factors, Sequential Organ Failure Assessment and Model for End-Stage Liver Disease scores for predicting short term mortality in cirrhotic patients admitted to intensive care unit","volume":"23","author":"Cholongitas","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"2022031703413039400_bib15","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1053\/jhep.2001.22172","article-title":"A model to predict survival in patients with end-stage liver disease","volume":"33","author":"Kamath","year":"2001","journal-title":"Hepatology"},{"key":"2022031703413039400_bib16","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1053\/j.gastro.2013.02.042","article-title":"Acute-on-chronic liver failure is a distinct syndrome developing in patients with acute decompensation in cirrhosis","volume":"144","author":"Moreau","year":"2013","journal-title":"Gastroenterology"},{"key":"2022031703413039400_bib17","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.jhep.2014.06.012","article-title":"Development and validation of a prognostic score to predict mortality in patients with acute-on-chronic liver failure","volume":"61","author":"Jalan","year":"2014","journal-title":"J Hepatol"},{"key":"2022031703413039400_bib18","doi-asserted-by":"crossref","first-page":"16","DOI":"10.2215\/CJN.03610417","article-title":"Prognosis of patients with cirrhosis and AKI who initiate RRT","volume":"13","author":"Allegretti","year":"2018","journal-title":"Clin J Am Soc Nephrol"},{"key":"2022031703413039400_bib19","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s12072-016-9706-9","article-title":"National trends of acute kidney injury requiring dialysis in decompensated cirrhosis hospitalizations in the United States","volume":"10","author":"Nadkarni","year":"2016","journal-title":"Hepatol Int"},{"key":"2022031703413039400_bib20","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1056\/NEJMra0809139","article-title":"Renal failure in cirrhosis","volume":"361","author":"Gine`s","year":"2009","journal-title":"N Engl J Med"},{"key":"2022031703413039400_bib21","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.2215\/CJN.01320216","article-title":"The role of RRT in hyperammonemic patients","volume":"11","author":"Gupta","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"key":"2022031703413039400_bib22","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/S0140-6736(21)00350-0","article-title":"Comparison of two delayed strategies for renal replacement therapy initiation for severe acute kidney injury (AKIKI 2): a multicentre, open-label, randomised, controlled trial","volume":"397","author":"Gaudry","year":"2021","journal-title":"Lancet North Am Ed"},{"key":"2022031703413039400_bib23","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1056\/NEJMoa1603017","article-title":"Initiation strategies for renal-replacement therapy in the intensive care unit","volume":"375","author":"Gaudry","year":"2016","journal-title":"N Engl J Med"},{"key":"2022031703413039400_bib24","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1056\/NEJMoa2000741","article-title":"Accelerated versus standard initiation of renal-replacement therapy in critically ill patients with acute kidney injury","volume":"383","author":"The STARRT-AKI Investigators","year":"2020","journal-title":"N Engl J Med"},{"key":"2022031703413039400_bib25","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1001\/jama.2016.5828","article-title":"Effect of early vs delayed initiation of renal replacement therapy on mortality in critically ill patients with acute kidney injury: the ELAIN randomized clinical trial","volume":"315","author":"Zarbock","year":"2016","journal-title":"JAMA"},{"key":"2022031703413039400_bib26","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.nefro.2020.07.016","article-title":"Renal replacement therapy in critically ill patients with acute kidney injury: 2020 nephrologist's perspective","volume":"41","author":"Valdenebro","year":"2021","journal-title":"Nefrologia"},{"key":"2022031703413039400_bib27","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/j.kint.2017.04.048","article-title":"Acute kidney injury in acute-on-chronic liver failure: where does hepatorenal syndrome fit?","volume":"92","author":"Davenport","year":"2017","journal-title":"Kidney Int"},{"key":"2022031703413039400_bib28","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/hep.30592","article-title":"Neutrophil gelatinase-associated lipocalin for assessment of acute kidney injury in cirrhosis: a prospective study","volume":"70","author":"Huelin","year":"2019","journal-title":"Hepatology"},{"key":"2022031703413039400_bib29","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1053\/j.ajkd.2020.03.016","article-title":"Clinical application of kidney biomarkers in cirrhosis","volume":"76","author":"Allegretti","year":"2020","journal-title":"Am J Kidney Dis"},{"key":"2022031703413039400_bib30","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1007\/s00134-014-3540-0","article-title":"Biomarkers for AKI improve clinical practice: no","volume":"41","author":"Ostermann","year":"2015","journal-title":"Intensive Care Med"},{"key":"2022031703413039400_bib31","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1007\/s00134-013-3061-2","article-title":"NGAL and AKI: the end of a myth?","volume":"39","author":"Legrand","year":"2013","journal-title":"Intensive Care Med"},{"key":"2022031703413039400_bib32","doi-asserted-by":"crossref","first-page":"e00359","DOI":"10.14309\/ctg.0000000000000359","article-title":"Urinary NGAL as a diagnostic and prognostic marker for acute kidney injury in cirrhosis: a prospective study","volume":"12","author":"Allegretti","year":"2021","journal-title":"Clin Transl Gastroenterol"},{"key":"2022031703413039400_bib33","article-title":"Hepatorenal syndrome","volume":"4","author":"Gin\u00e8s","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"2022031703413039400_bib34","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1007\/s00134-019-05919-0","article-title":"Identification and validation of biomarkers of persistent acute kidney injury: the RUBY study","volume":"46","author":"Hoste","year":"2020","journal-title":"Intensive Care Med"},{"key":"2022031703413039400_bib35","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1097\/CCM.0000000000004193","article-title":"Guidelines for the management of adult acute and acute-on-chronic liver failure in the ICU: cardiovascular, endocrine, hematologic, pulmonary and renal considerations: executive summary","volume":"48","author":"Nanchal","year":"2020","journal-title":"Crit Care Med"},{"key":"2022031703413039400_bib36","first-page":"679","article-title":"Continuous renal replacement therapy","volume":"21","author":"Deep","year":"2016","journal-title":"Clin Pediatr Nephrol"},{"key":"2022031703413039400_bib37","article-title":"Effects of continuous and intermittent renal replacement therapies among adult patients with acute kidney injury","volume":"13","author":"Schoenfelder","year":"2017","journal-title":"GMS Health Technol Assess"},{"key":"2022031703413039400_bib38","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1097\/01.CCM.0B013E3181611F552","article-title":"Continuous versus intermittent renal replacement therapy for critically ill patients with acute kidney injury: a meta-analysis","volume":"36","author":"Bagshaw","year":"2008","journal-title":"Crit Care Med"},{"key":"2022031703413039400_bib39","first-page":"CD003773","article-title":"Intermittent versus continuous renal replacement therapy for acute renal failure in adults","volume":"3","author":"Rabindranath","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"2022031703413039400_bib40","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1093\/ndt\/gfn560","article-title":"Intermittent versus continuous renal replacement therapy for acute kidney injury patients admitted to the intensive care unit: results of a randomized clinical trial","volume":"24","author":"Lins","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"2022031703413039400_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/cc9345","article-title":"Pro\/con debate: continuous versus intermittent dialysis for acute kidney injury: a never-ending story yet approaching the finish?","volume":"15","author":"Vanholder","year":"2010","journal-title":"Crit Care"},{"key":"2022031703413039400_bib42","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S0140-6736(06)69111-3","article-title":"Continuous venovenous haemodiafiltration versus intermittent haemodialysis for acute renal failure in patients with multiple-organ dysfunction syndrome: a multicentre randomised trial","volume":"368","author":"Vinsonneau","year":"2006","journal-title":"Lancet"},{"key":"2022031703413039400_bib43","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1159\/000334149","article-title":"The challenges of providing renal replacement therapy in decompensated liver cirrhosis","volume":"33","author":"Gonwa","year":"2012","journal-title":"Blood Purif"},{"key":"2022031703413039400_bib44","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1111\/j.1523-1755.2005.00408.x","article-title":"Survival of liver transplant candidates with acute renal failure receiving renal replacement therapy","volume":"68","author":"Wong","year":"2005","journal-title":"Kidney Int"},{"key":"2022031703413039400_bib45","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/hep.30592","article-title":"Neutrophil gelatinase-associated lipocalin for assessment of acute kidney injury in cirrhosis: a prospective study","volume":"70","author":"Huelin","year":"2019","journal-title":"Hepatology"},{"key":"2022031703413039400_bib46","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/cld.976","article-title":"Current concepts in coagulation profile in cirrhosis and acute-on-chronic liver failure","volume":"16","author":"Premkumar","year":"2020","journal-title":"Clinical Liver Disease"},{"key":"2022031703413039400_bib47","first-page":"31","article-title":"Bleeding complications in critically ill patients with liver cirrhosis","author":"Cho","year":"2016","journal-title":"Korean J Intern Med"},{"key":"2022031703413039400_bib48","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.jhep.2015.10.019","article-title":"Management of the critically ill patient with cirrhosis: a multidisciplinary perspective","volume":"64","author":"Nadim","year":"2016","journal-title":"J Hepatol"},{"key":"2022031703413039400_bib49","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1002\/hep.31201","article-title":"Hemostatic alterations in patients with cirrhosis: from primary hemostasis to fibrinolysis","volume":"71","author":"Zermatten","year":"2020","journal-title":"Hepatology"},{"key":"2022031703413039400_bib50","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1001\/jama.2020.18618","article-title":"Effect of regional citrate anticoagulation vs systemic heparin anticoagulation during continuous kidney replacement therapy on dialysis filter life span and mortality among critically ill patients with acute kidney injury: a randomized clinical trial","volume":"324","author":"Zarbock","year":"2020","journal-title":"JAMA"},{"key":"2022031703413039400_bib51","doi-asserted-by":"crossref","first-page":"207","DOI":"10.5005\/jp-journals-10071-23721","article-title":"Renal dysfunction in cirrhosis: critical care management","volume":"25","author":"Rajakumar","year":"2021","journal-title":"Indian J Crit Care Med"},{"key":"2022031703413039400_bib52","doi-asserted-by":"crossref","first-page":"744.e7","DOI":"10.1016\/j.jcrc.2012.08.016","article-title":"Circuit lifespan during continuous renal replacement therapy for combined liver and kidney failure","volume":"27","author":"Chua","year":"2012","journal-title":"J Crit Care"},{"key":"2022031703413039400_bib53","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.jhep.2009.05.028","article-title":"Continuous renal replacement therapy (CRRT) in patients with liver disease: is circuit life different?","volume":"51","author":"Agarwal","year":"2009","journal-title":"J Hepatol"},{"key":"2022031703413039400_bib54","doi-asserted-by":"publisher","first-page":"c179","DOI":"10.1159\/000339789","article-title":"KDIGO clinical practice guidelines for acute kidney injury","volume":"120","author":"Khwaja","year":"2012","journal-title":"Nephron Clin Pract"},{"key":"2022031703413039400_bib55","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1001\/jama.2020.18618","article-title":"Effect of regional citrate anticoagulation vs systemic heparin anticoagulation during continuous kidney replacement therapy on dialysis filter life span and mortality among critically ill patients with acute kidney injury: a randomized clinical trial","volume":"324","author":"Zarbock","year":"2020","journal-title":"JAMA"},{"key":"2022031703413039400_bib56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13054-017-1880-1","article-title":"Complications of regional citrate anticoagulation: accumulation or overload?","volume":"21","author":"Schneider","year":"2017","journal-title":"Crit Care"},{"key":"2022031703413039400_bib57","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1097\/01.CCM.0000084871.76568.E6","article-title":"Citrate pharmacokinetics and metabolism in cirrhotic and noncirrhotic critically ill patients","volume":"31","author":"Kramer","year":"2003","journal-title":"Crit Care Med"},{"key":"2022031703413039400_bib58","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13054-017-1870-3","article-title":"Long-term continuous renal replacement therapy and anticoagulation with citrate in critically ill patients with severe liver dysfunction","volume":"21","author":"Klingele","year":"2017","journal-title":"Crit Care"},{"key":"2022031703413039400_bib59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13054-019-2317-9","article-title":"Safety and efficacy of regional citrate anticoagulation for continuous renal replacement therapy in liver failure patients: a systematic review and meta-analysis","volume":"23","author":"Zhang","year":"2019","journal-title":"Crit Care"},{"key":"2022031703413039400_bib60","doi-asserted-by":"crossref","first-page":"R162","DOI":"10.1186\/cc11485","article-title":"Continuous venovenous hemodialysis with regional citrate anticoagulation in patients with liver failure: a prospective observational study","volume":"16","author":"Schulthei\u00df","year":"2012","journal-title":"Crit Care"},{"key":"2022031703413039400_bib61","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1097\/CCM.0000000000004617","article-title":"Fluid overload and mortality in adult critical care patients\u2014A systematic review and meta-analysis of observational studies","volume":"45","author":"Messmer","year":"2020","journal-title":"Crit Care Med"},{"key":"2022031703413039400_bib62","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/MAJ.0000000000000268","article-title":"New insight into volume overload and hepatorenal syndrome in cirrhosis, \u201cthe hepatorenal reflex hypothesis","volume":"348","author":"Rzouq","year":"2014","journal-title":"Am J Med Sci"},{"key":"2022031703413039400_bib63","doi-asserted-by":"crossref","first-page":"34","DOI":"10.2174\/1570161118666200225093827","article-title":"Assessment and management of volume overload among patients on chronic dialysis","volume":"19","author":"Covic","year":"2021","journal-title":"Curr Vasc Pharmacol"},{"key":"2022031703413039400_bib64","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1159\/000504079","article-title":"Using bioimpedance spectroscopy to assess volume status in dialysis patients","volume":"49","author":"Van der Sande","year":"2020","journal-title":"Blood Purif"},{"key":"2022031703413039400_bib65","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1093\/ndt\/gfi056","article-title":"Measurement of relative blood volume changes during haemodialysis: merits and limitations","volume":"20","author":"Dasselaar","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"2022031703413039400_bib66","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1053\/ajkd.2002.36894","article-title":"The role of blood volume reduction in the genesis of intraidytic hypotension","volume":"40","author":"Andrulli","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"2022031703413039400_bib67","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1159\/000433415","article-title":"Relative blood volume monitoring during renal replacement therapy in critically ill patients with septic shock: a preliminary report","volume":"40","author":"Kron","year":"2015","journal-title":"Blood Purif"},{"key":"2022031703413039400_bib68","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s13054-020-03441-0","article-title":"A randomized trial of albumin infusion to prevent intradialytic hypotension in hospitalized hypoalbuminemic patients","volume":"25","author":"Macedo","year":"2021","journal-title":"Crit Care"},{"key":"2022031703413039400_bib69","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1111\/nep.12677","article-title":"Sodium modelling to reduce intradialytic hypotension during haemodialysis for acute kidney injury in the intensive care unit","volume":"21","author":"Lynch","year":"2016","journal-title":"Nephrology (Carlton)"},{"key":"2022031703413039400_bib70","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1002\/lt.25773","article-title":"Intraoperative continuous renal replacement therapy during liver transplantation: a meta-analysis","volume":"26","author":"Huang","year":"2020","journal-title":"Liver Transpl"},{"key":"2022031703413039400_bib71","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13054-016-1225-5","article-title":"Daily urinary urea excretion to guide intermittent hemodialysis weaning in critically ill patients","volume":"20","author":"Aniort","year":"2016","journal-title":"Crit Care"},{"key":"2022031703413039400_bib72","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1097\/CCM.0b013e3181a38241","article-title":"Discontinuation of continuous renal replacement therapy: a post hoc analysis of a prospective multicenter observational study","volume":"37","author":"Uchino","year":"2009","journal-title":"Crit Care Med"},{"key":"2022031703413039400_bib73","doi-asserted-by":"crossref","first-page":"744.e1","DOI":"10.1016\/j.jcrc.2012.08.012","article-title":"Use of 2-hour creatinine clearance to guide cessation of continuous renal replacement therapy","volume":"27","author":"Fr\u00f6hlich","year":"2012","journal-title":"J Crit Care"},{"key":"2022031703413039400_bib74","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s00134-007-0813-x","article-title":"Risk factors of early redialysis after weaning from postoperative acute renal replacement therapy","volume":"34","author":"Wu","year":"2008","journal-title":"Intensive Care Med"},{"key":"2022031703413039400_bib75","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s40620-015-0224-y","article-title":"Sustained low-efficiency extended dialysis (SLED) with single-pass batch system in critically ill patients with acute kidney injury (AKI)","volume":"29","author":"Caires","year":"2016","journal-title":"J Nephrol"},{"key":"2022031703413039400_bib76","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1186\/cc5922","article-title":"Bench-to-bedside review: current evidence for extracorporeal albumin dialysis systems in liver failure","volume":"11","author":"Karvellas","year":"2007","journal-title":"Crit Care"},{"key":"2022031703413039400_bib77","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13054-015-1159-3","article-title":"Molecular adsorbent recirculating system and single-pass albumin dialysis in liver failure\u2014a prospective, randomised crossover study","volume":"20","author":"Sponholz","year":"2016","journal-title":"Crit Care"},{"key":"2022031703413039400_bib78","doi-asserted-by":"crossref","first-page":"3633","DOI":"10.1093\/ndt\/gfr115","article-title":"Comparison of Molecular Adsorbents Recirculating System (MARS) dialysis with combined plasma exchange and haemodialysis in children with acute liver failure","volume":"26","author":"Schaefer","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"2022031703413039400_bib79","article-title":". Madrid","author":"Anaya","year":"2005","journal-title":"Af\u00e9resis terap\u00e9utica"},{"key":"2022031703413039400_bib80","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1111\/j.1744-9987.2006.00354.x","article-title":"Review article: clinical experience with prometheus","volume":"10","author":"Rifai","year":"2006","journal-title":"Ther Apher Dial"},{"key":"2022031703413039400_bib81","doi-asserted-by":"crossref","first-page":"376","DOI":"10.5414\/CNP58376","article-title":"Characterization of treatment dose delivered by albumin dialysis in the treatment of acute renal failure associated with severe hepatic dysfunction","volume":"58","author":"McIntyre","year":"2002","journal-title":"Clin Nephrol"}],"container-title":["Clinical Kidney Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ckj\/advance-article-pdf\/doi\/10.1093\/ckj\/sfac025\/42927039\/sfac025.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ckj\/advance-article-pdf\/doi\/10.1093\/ckj\/sfac025\/42927039\/sfac025.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,16]],"date-time":"2023-11-16T02:23:54Z","timestamp":1700101434000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ckj\/advance-article\/doi\/10.1093\/ckj\/sfac025\/6516945"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,28]]},"references-count":81,"URL":"https:\/\/doi.org\/10.1093\/ckj\/sfac025","relation":{},"ISSN":["2048-8505","2048-8513"],"issn-type":[{"value":"2048-8505","type":"print"},{"value":"2048-8513","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,28]]},"article-number":"sfac025"}}